Marco Eisl

Marco Eisl possesses extensive experience in the pharmaceutical and biotechnology sectors, having held key leadership roles in commercial and marketing functions. Notably, Marco served as the Commercial Head for Switzerland and Austria at Biogen, and prior to that, as Marketing Director for Germany at Moderna. Marco's expertise also includes roles at Takeda in Deutschland as Business Unit Head for Rare Hematology and as Head of Business Operations in Hematology at Takeda Pharmaceuticals. Additionally, Marco contributed to the launch of important products at Shire as Launch Lead for Veyvondi and PM Obizur in Germany. Educationally, Marco holds a Master of Science degree in Strategic Marketing from Maastricht University.